Author: Syed Faraz Ahmed; Ahmed A. Quadeer; Matthew R. McKay
Title: Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies Document date: 2020_2_4
ID: 7i52vltp_29
Snippet: Research efforts directed towards the design and development of vaccines for SARS-CoV-2 are increasing, and some related analyses are already being reported in distinct, parallel studies. Notably, a preliminary analysis of linear B cell epitopes has been reported online on the ViPR database website (https://www.viprbrc.org/brcDocs/documents/announcements/Corona/2019-nCoV-ViPR-report_24JAN2020.pdf). Different from our study, which is focused on th.....
Document: Research efforts directed towards the design and development of vaccines for SARS-CoV-2 are increasing, and some related analyses are already being reported in distinct, parallel studies. Notably, a preliminary analysis of linear B cell epitopes has been reported online on the ViPR database website (https://www.viprbrc.org/brcDocs/documents/announcements/Corona/2019-nCoV-ViPR-report_24JAN2020.pdf). Different from our study, which is focused on the linear and discontinuous SARS-CoV-derived epitopes, that analysis considered linear B cell epitope data for all Betacoronaviruses from human hosts. While only a summary of the results has been provided so far, preventing direct comparison of the individual epitopes, the number of linear B cell epitopes reported to map identically to SARS-CoV-2 is comparable to our findings.
Search related documents:
Co phrase search for related documents- cell epitope and human host: 1, 2, 3, 4, 5, 6
- cell epitope and individual epitope: 1, 2, 3, 4, 5, 6, 7
- cell epitope and related analysis: 1, 2, 3
- cell epitope and SARS vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52
- development design and human host: 1, 2, 3, 4
- development design and online report: 1
- development design and preliminary analysis: 1
- development design and related analysis: 1, 2, 3
- development design and SARS vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
- development design and SARS vaccine development design: 1, 2, 3, 4, 5, 6, 7, 8, 9
- direct comparison and preliminary analysis: 1
- direct comparison and related analysis: 1, 2
Co phrase search for related documents, hyperlinks ordered by date